Cargando…
FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer
Identification of noncoding drivers from thousands of somatic alterations in a typical tumor is a difficult and unsolved problem. We report a computational framework, FunSeq2, to annotate and prioritize these mutations. The framework combines an adjustable data context integrating large-scale genomi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203974/ https://www.ncbi.nlm.nih.gov/pubmed/25273974 http://dx.doi.org/10.1186/s13059-014-0480-5 |
_version_ | 1782340476322447360 |
---|---|
author | Fu, Yao Liu, Zhu Lou, Shaoke Bedford, Jason Mu, Xinmeng Jasmine Yip, Kevin Y Khurana, Ekta Gerstein, Mark |
author_facet | Fu, Yao Liu, Zhu Lou, Shaoke Bedford, Jason Mu, Xinmeng Jasmine Yip, Kevin Y Khurana, Ekta Gerstein, Mark |
author_sort | Fu, Yao |
collection | PubMed |
description | Identification of noncoding drivers from thousands of somatic alterations in a typical tumor is a difficult and unsolved problem. We report a computational framework, FunSeq2, to annotate and prioritize these mutations. The framework combines an adjustable data context integrating large-scale genomics and cancer resources with a streamlined variant-prioritization pipeline. The pipeline has a weighted scoring system combining: inter- and intra-species conservation; loss- and gain-of-function events for transcription-factor binding; enhancer-gene linkages and network centrality; and per-element recurrence across samples. We further highlight putative drivers with information specific to a particular sample, such as differential expression. FunSeq2 is available from funseq2.gersteinlab.org. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13059-014-0480-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4203974 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42039742014-10-23 FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer Fu, Yao Liu, Zhu Lou, Shaoke Bedford, Jason Mu, Xinmeng Jasmine Yip, Kevin Y Khurana, Ekta Gerstein, Mark Genome Biol Method Identification of noncoding drivers from thousands of somatic alterations in a typical tumor is a difficult and unsolved problem. We report a computational framework, FunSeq2, to annotate and prioritize these mutations. The framework combines an adjustable data context integrating large-scale genomics and cancer resources with a streamlined variant-prioritization pipeline. The pipeline has a weighted scoring system combining: inter- and intra-species conservation; loss- and gain-of-function events for transcription-factor binding; enhancer-gene linkages and network centrality; and per-element recurrence across samples. We further highlight putative drivers with information specific to a particular sample, such as differential expression. FunSeq2 is available from funseq2.gersteinlab.org. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13059-014-0480-5) contains supplementary material, which is available to authorized users. BioMed Central 2014-10-02 2014 /pmc/articles/PMC4203974/ /pubmed/25273974 http://dx.doi.org/10.1186/s13059-014-0480-5 Text en © Fu et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Method Fu, Yao Liu, Zhu Lou, Shaoke Bedford, Jason Mu, Xinmeng Jasmine Yip, Kevin Y Khurana, Ekta Gerstein, Mark FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer |
title | FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer |
title_full | FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer |
title_fullStr | FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer |
title_full_unstemmed | FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer |
title_short | FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer |
title_sort | funseq2: a framework for prioritizing noncoding regulatory variants in cancer |
topic | Method |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203974/ https://www.ncbi.nlm.nih.gov/pubmed/25273974 http://dx.doi.org/10.1186/s13059-014-0480-5 |
work_keys_str_mv | AT fuyao funseq2aframeworkforprioritizingnoncodingregulatoryvariantsincancer AT liuzhu funseq2aframeworkforprioritizingnoncodingregulatoryvariantsincancer AT loushaoke funseq2aframeworkforprioritizingnoncodingregulatoryvariantsincancer AT bedfordjason funseq2aframeworkforprioritizingnoncodingregulatoryvariantsincancer AT muxinmengjasmine funseq2aframeworkforprioritizingnoncodingregulatoryvariantsincancer AT yipkeviny funseq2aframeworkforprioritizingnoncodingregulatoryvariantsincancer AT khuranaekta funseq2aframeworkforprioritizingnoncodingregulatoryvariantsincancer AT gersteinmark funseq2aframeworkforprioritizingnoncodingregulatoryvariantsincancer |